Category Archives: News and Events

BriaCell Announces Collaboration with the National Cancer Institute

• BriaCell and National Cancer Institute to collaborate on Bria-OTS™, BriaCell’s off-the-shelf personalized immunotherapy, as ...

BriaCell Breast Cancer Survival Data: 13.3 Months Versus 7.2-9.8 Months

• Overall Survival of 13.3 months in patients, including 14 months in patients with Grade ...

BriaCell to Present Clinical Findings at the 2020 San Antonio Breast Cancer Symposium®, December 9 – 11

• Clinical and pathological findings to be presented from clinical trial of the Bria-IMT™ regimen ...

Note from BriaCell Management – October is Breast Cancer Awareness Month

BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell to Present at the 3rd Annual Biologics World Nordic 2020

BERKELEY, Calif., and VANCOUVER, British Columbia, September 15, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Awarded Research Grant from Wiseman Cancer Research Foundation

BERKELEY, Calif., and VANCOUVER, British Columbia, September 4, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Therapeutics Corp. Announces Completion of Shares for Debt Issuance

BERKELEY, Calif., and VANCOUVER, British Columbia, August 17, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Presents Clinical and Scientific Findings at the Annual Symposium of Society of Surgical Oncology 2020

Preliminary safety and efficacy data are being presented today from the clinical trials of Bria-IMT™ ...

BriaCell Therapeutics Corp. Announces Shares for Debt Issuance

BERKELEY, Calif., and VANCOUVER, British Columbia, August 11, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Files Provisional Patent Application for Novel Treatment and Diagnosis of Coronavirus Disease

BERKELEY, Calif., and VANCOUVER, British Columbia, June 24, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...